What is the recommended treatment for an acute gout flare?

Treatment of Acute Gout Flare

First-Line Pharmacologic Options

Corticosteroids should be your first choice for treating acute gout because they match NSAIDs in efficacy while causing fewer adverse effects and costing less. 1, 2

Corticosteroids (Preferred First-Line)

• Prescribe prednisolone 35 mg orally once daily for 5 days as the standard regimen for acute gout flares 1, 2
• Corticosteroids work by targeting the inflammatory response to urate crystal deposition and have been proven as effective as NSAIDs with superior safety profiles 1
• Contraindications: systemic fungal infections and known hypersensitivity 2
• Short-term adverse effects include mood disturbances, elevated blood glucose, immunosuppression, and fluid retention 1, 2

NSAIDs (Alternative First-Line)

• All NSAIDs demonstrate equivalent efficacy—indomethacin offers no advantage over naproxen or ibuprofen despite being traditionally favored 1, 2
• This is a critical pitfall to avoid: moderate-quality evidence definitively shows no difference between NSAID types 1
• Absolute contraindications: renal disease, heart failure, and cirrhosis 1, 2
• Major risks include dyspepsia, gastrointestinal perforation, ulceration, and bleeding 1

Colchicine (Alternative First-Line)

• Use low-dose colchicine: 1.2 mg followed by 0.6 mg one hour later 1, 2
• This low-dose regimen equals the efficacy of high-dose schedules (1.2 mg followed by 0.6 mg hourly for 6 hours) but dramatically reduces gastrointestinal toxicity—diarrhea occurs in 23% versus 77% with high-dose 2
• Never use high-dose colchicine regimens—they provide zero additional benefit while causing significantly more adverse effects 2
• Colchicine remains more expensive than NSAIDs or corticosteroids 1, 2
• Contraindications: renal or hepatic impairment in patients taking potent CYP3A4 or P-glycoprotein inhibitors 1, 2
• Common adverse effects: diarrhea, nausea, vomiting, abdominal cramps, and occasionally headache and fatigue 1, 2

Initiating Urate-Lowering Therapy During Acute Flare

You can safely start urate-lowering therapy (ULT) during an acute gout flare—it does not prolong or worsen the flare. 2

• Starting ULT during the acute episode improves care efficiency and capitalizes on patient motivation when symptoms are fresh 2
• Mandatory requirement: provide concomitant anti-inflammatory prophylaxis when initiating ULT to prevent subsequent flares 2
• Prophylaxis duration: continue for 3–6 months rather than shorter courses under 3 months 2
• Acceptable prophylactic agents include colchicine, NSAIDs, or low-dose corticosteroids 2
• Reassess regularly and extend prophylaxis if flares persist beyond the initial period 2
• After stopping prophylaxis, expect a temporary spike in flare risk—29.7% of patients experience flares in the three-month period immediately after discontinuation, compared to 14.7% during prophylaxis 3

When NOT to Start Long-Term ULT

Do not initiate long-term urate-lowering therapy after a first gout attack or in patients with infrequent attacks (fewer than 2 per year). 1

• Evidence supports ULT benefits for shorter durations, but long-term use (≥12 months) has not been studied in patients with single or infrequent attacks 1
• ULT is unnecessary when patients would have no or infrequent recurrences 1
• Indications for considering ULT: recurrent gout (≥2 episodes per year) or problematic gout (tophi, chronic kidney disease, urolithiasis) 1, 2

Key Clinical Pitfalls to Avoid

• Stop prescribing indomethacin preferentially—it has no superiority over other NSAIDs 1, 2
• Avoid high-dose colchicine—it causes 77% diarrhea rates versus 23% with low-dose for identical efficacy 2
• Do not delay ULT in recurrent or problematic gout—waiting serves no purpose and prolongs disease burden 2
• Never skip prophylaxis when starting ULT—this is mandatory to prevent flare precipitation 2
• Do not use NSAIDs in patients with renal disease, heart failure, or cirrhosis—these are absolute contraindications 1, 4